Ocular Drug Delivery Technology Market
Ocular Drug Delivery Technology Market Analysis By Type (Topical, Ocular, Iontophoresis), By Formulation (Solution based, Suspension based, Emulsion based), By Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome), By Region - Global Insights 2022 to 2032
According to Fact.MR estimates, the Ocular Drug Delivery Technology market stood at USD 22.4 billion in 2025. The market is projected to reach USD 24.3 billion in 2026 and climb to USD 53.5 billion by 2036, progressing at a CAGR of 8.2%. Solution-based formulations are anticipated to account for nearly 60% share of the formulation segment, while intraocular implants are expected to remain the leading technology segmentby having 54%, driven by increasing prevalence of eye diseases such as glaucoma, cataract, and macular degeneration, rising geriatric population, and growing demand for targeted drug delivery techniques for posterior eye disorders.
- FACT4802MR
- 25 Apr 2022
- Healthcare
- 170 Pages
- 42 Tables
- 94 Figures
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Ocular Drug Delivery Disease Type Market
- 4. Market Overview
- 5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
- 5.1. Topical
- 5.2. Ocular Insert
- 5.2.1. Erodible
- 5.2.2. Non-Erodible
- 5.3. Iontophoresis
- 5.4. Intraocular Implant
- 5.4.1. Biodegradable
- 5.4.2. Non-Biodegradable
- 5.5. In Situ Gel & Punctal Plug
- 5.6. Others
- 6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type
- 6.1. Solution
- 6.2. Suspension
- 6.3. Emulsion
- 6.4. Liposomes & Nanoparticles
- 6.5. Ointments
- 7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
- 7.1. Diabetic Retinopathy
- 7.2. Macular Degeneration
- 7.3. Cataract
- 7.4. Glaucoma
- 7.5. Diabetic Macular Edema
- 7.6. Dry Eye Syndrome
- 7.7. Others
- 8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User
- 8.1. Hospitals
- 8.2. Ambulatory Surgical Centers
- 8.3. Ophthalmic Clinics
- 8.4. Homecare Settings
- 9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East & Africa
- 10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 15. Competition Landscape
- 15.1. OCULAR THERAPEUTIX, INC.
- 15.2. Alimera Sciences
- 15.3. Allergan, Plc
- 15.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
- 15.5. EyeGate Pharma
- 15.6. Envisia Therapeutics
- 15.7. Clearside Biomedical, INC.
- 15.8. Graybug Vision Inc
- 15.9. Santen Pharmaceutical Co., Ltd
- 15.10. Taiwan Liposome Company, Ltd
List Of Table
Table 01: Global Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 02: Global Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 03: Global Market Size (US$ Mn) Forecast, Intraocular Implants, 2022 to 2032
Table 04: Global Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 05: Global Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 06: Global Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2022 to 2032
Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 09: North America Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 10: North America Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 11: North America Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 12: North America Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 13: North America Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 14: North America Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 15: Europe Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 16: Europe Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 17: Europe Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 18: Europe Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 19: Europe Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 20: Europe Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 21: Europe Market Size (US$ Mn) Forecast, by End Users, 2022 to 2032
Table 22: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 23: Asia Pacific Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 24: Asia Pacific Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2022 to 2032
Table 25: Asia Pacific Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2022 to 2032
Table 26: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 27: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 28: Asia Pacific Market Size (US$ Mn) Forecast, by End User, 2022 to 2032
Table 29: Latin America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 30: Latin America Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 31: Latin America Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 32: Latin America Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 33: Latin America Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 34: Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 35: Latin America Market Size (US$ Mn) Forecast, by End Users, 2022 to 2032
Table 36: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 37: Middle East & Africa Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 38: Middle East & Africa Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 39: Middle East & Africa Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 40: Middle East & Africa Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 41: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 42: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
List Of Figures
Figure 1: Global Market Size (US$ Mn) Forecast, 2022 to 2032
Figure 2: Global Market Value Share, by Technology Type (2018)
Figure 3: Global Market Value Share, by Formulations Type (2018)
Figure 04: Global Market Value Share, by Disease Type (2018)
Figure 05: Global Market Value Share, by Region (2018)
Figure 06: Global Market Value Share, by End-user (2018)
Figure 07: Global Market Value Share, by Technology Type, 2022 and 2032
Figure 08: Global Market Attractiveness, by Technology Type, 2022 to 2032
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2022 to 2032
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2022 to 2032
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2022 to 2032
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2022 to 2032
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2022 to 2032
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2022 to 2032
Figure 15: Global Market Value Share, by Formulation Type, 2022 and 2032
Figure 16: Global Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2022 to 2032
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2022 to 2032
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2022 to 2032
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2022 to 2032
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2022 to 2032
Figure 22: Global Market Value Share, by Disease Type, 2022 and 2032
Figure 23: Global Market Attractiveness, by Disease Type, 2022 to 2032
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2022 to 2032
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2022 to 2032
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2022 to 2032
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2022 to 2032
Figure 28: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2022 to 2032
Figure 29: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2022 to 2032
Figure 30: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2022 to 2032
Figure 31: Global Market Value Share, by End-user, 2022 and 2032
Figure 32: Global Market Attractiveness, by End-user, 2022 to 2032
Figure 33: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022 to 2032
Figure 34: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2022 to 2032
Figure 35: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2022 to 2032
Figure 36: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2022 to 2032
Figure 37: Global Market Value Share, by Region, 2022 and 2032
Figure 38: Global Market Attractiveness, by Region, 2022 to 2032
Figure 39: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 40: North America Market Value Share, by Country, 2022 and 2032
Figure 41: North America Market Attractiveness, 2022 to 2032
Figure 42: North America Market Value Share, by Technology Type, 2022 and 2032
Figure 43: North America Market Attractiveness, by Technology Type, 2022 to 2032
Figure 44: North America Market Value Share, by Formulation Type, 2022 and 2032
Figure 45: North America Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 46: North America Market Value Share, by Disease Type, 2022 and 2032
Figure 47: North America Market Attractiveness, by Disease Type, 2022 to 2032
Figure 48: North America Market Value Share, by End-user, 2022 and 2032
Figure 49: North America Market Attractiveness, by End-user, 2022 to 2032
Figure 50: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 51: Europe Market Value Share, by Country, 2022 and 2032
Figure 52: Europe Market Attractiveness, by Country, 2022 to 2032
Figure 53: Europe Market Value Share, by Technology Type, 2022 and 2032
Figure 54: Europe Market Attractiveness, by Technology Type, 2022 to 2032
Figure 55: Europe Market Value Share, by Formulation Type, 2022 and 2032
Figure 56: Europe Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 57: Europe Market Value Share, by Disease Type, 2022 and 2032
Figure 58: Europe Market Attractiveness, by Disease Type, 2022 to 2032
Figure 59: Europe Market Value Share, by End Users, 2022 and 2032
Figure 60: Europe Market Attractiveness, by End Users, 2022 to 2032
Figure 61: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 62: Asia Pacific Market Value Share, by Country, 2022 and 2032
Figure 63: Asia Pacific Market Attractiveness, by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value Share, by Technology Type, 2022 and 2032
Figure 65: Asia Pacific Market Attractiveness, by Technology Type, 2022 to 2032
Figure 66: Asia Pacific Market Value Share, by Formulation Type, 2022 and 2032
Figure 67: Asia Pacific Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 68: Asia Pacific Market Value Share, by Disease Type, 2022 and 2032
Figure 69: Asia Pacific Market Attractiveness, by Disease Type, 2022 to 2032
Figure 70: Asia Pacific Market Value Share, by End User, 2022 and 2032
Figure 71: Asia Pacific Market Attractiveness, by End User, 2022 to 2032
Figure 72: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 73: Latin America Market Value Share, by Country, 2022 and 2032
Figure 74: Latin America Market Attractiveness, by Country, 2022 to 2032
Figure 75: Latin America Market Value Share, by Technology Type, 2022 and 2032
Figure 76: Latin America Market Attractiveness, by Technology Type, 2022 to 2032
Figure 77: Latin America Market Value Share, by Formulation Type, 2022 and 2032
Figure 78: Latin America Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 79: Latin America Market Value Share, by Disease Type, 2022 and 2032
Figure 80: Latin America Market Attractiveness, by Disease Type, 2022 to 2032
Figure 81: Latin America Market Value Share, by End Users, 2022 and 2032
Figure 82: Latin America Market Attractiveness, by End Users, 2022 to 2032
Figure 83: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 84: Middle East & Africa Market Value Share, by Country, 2022 and 2032
Figure 85: Middle East & Africa Market Attractiveness, by Country, 2022 to 2032
Figure 86: Middle East & Africa Market Value Share, by Technology Type, 2022 and 2032
Figure 87: Middle East & Africa Market Attractiveness, by Technology Type, 2022 to 2032
Figure 88: Middle East & Africa Market Value Share, by Formulation Type, 2022 and 2032
Figure 89: Middle East & Africa Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 90: Middle East & Africa Market Value Share, by Disease Type, 2022 and 2032
Figure 91: Middle East & Africa Market Attractiveness, by Disease Type, 2022 to 2032
Figure 92: Middle East & Africa Market Value Share, by End-user, 2022 and 2032
Figure 93: Middle East & Africa Market Attractiveness, by End-user, 2022 to 2032
Figure 94: Global Market Share, by Company, 2021
Ocular Drug Delivery Technology Market